DIA/Harvard-MIT CRS Accelerating Cell and Gene Therapy Executive Roundtable

Updates from the FDA

Peter Marks, MD, PhD

Senior Vice President, Molecul, Eli Lilly and Company, United States

Updates from the FDA

Nicole Verdun, MD

Director, Office of Therapeutic Products, CBER, FDA, United States